Best Practice & Research Clinical Rheumatology
Volume 20, Issue 3 , Pages 521-537 , June 2006

Assessments in ankylosing spondylitis

  • Jane Zochling, MBBS, MMed(ClinEpi), PhD (Post-doctoral Research Fellow)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +49 2325 592 720; fax: +49 2325 592 136.

References 

  1. van der Heijde D, Bellamy N, Calin A, et al. Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in ankylosing spondylitis working group. The Journal of Rheumatology. 1997;24:2225–2229
  2. van der Heijde D, van der Linden S, Dougados M, et al. Ankylosing spondylitis: plenary discussion and results of voting on selection of domains and some specific instruments. The Journal of Rheumatology. 1999;26:1003–1005
  3. van der Heijde D, van der Linden S, Bellamy N, et al. Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV. The Journal of Rheumatology. 1999;26:945–947
  4. van der Heijde D, Calin A, Dougados M, et al. Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS working group. Assessments in ankylosing spondylitis. The Journal of Rheumatology. 1999;26:951–954
  5. Boers M, Brooks P, Strand CV, Tugwell P. The OMERACT filter for outcome measures in rheumatology. The Journal of Rheumatology. 1998;25:198–199
  6. Calin A, Porta J, Fries JF, Schurman DJ. Clinical history as a screening test for ankylosing spondylitis. J Am Med Assoc. 1977;237:2613–2614
  7. Gran JT, Husby G, Hordvik M. Spinal ankylosing spondylitis: a variant form of ankylosing spondylitis or a distinct disease entity?. Annals of the Rheumatic Diseases. 1985;44:368–371
  8. Rudwaleit M, Metter A, Listing J, et al. Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis and Rheumatism. 2006;54:569–578
  9. Salaffi F, Stancati A, Silvestri CA, et al. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. European Journal of Pain (London, England). 2004;8:283–291
  10. Auleley GR, Benbouazza K, Spoorenberg A, et al. Evaluation of the smallest detectable difference in outcome or process variables in ankylosing spondylitis. Arthritis and Rheumatism. 2002;47:582–587
  11. Ward MM. Health-related quality of life in ankylosing spondylitis: a survey of 175 patients. Arthritis Care and Research. 1999;12:247–255
  12. Jones SD, Koh WH, Steiner A, et al. Fatigue in ankylosing spondylitis: its prevalence and relationship to disease activity, sleep, and other factors. The Journal of Rheumatology. 1996;23:487–490
  13. van Tubergen A, Coenen J, Landewe R, et al. Assessment of fatigue in patients with ankylosing spondylitis: a psychometric analysis. Arthritis and Rheumatism. 2002;47:8–16
  14. Calin A, Edmunds L, Kennedy LG. Fatigue in ankylosing spondylitis—why is it ignored?. The Journal of Rheumatology. 1993;20:991–995
  15. Dernis-Labous E, Messow M, Dougados M. Assessment of fatigue in the management of patients with ankylosing spondylitis. Rheumatology (Oxford, England). 2003;42:1523–1528
  16. Dagfinrud H, Vollestad NK, Loge JH, et al. Fatigue in patients with ankylosing spondylitis: a comparison with the general population and associations with clinical and self-reported measures. Arthritis and Rheumatism. 2005;53:5–11
  17. Garrett S, Jenkinson T, Kennedy LG, et al. new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. The Journal of Rheumatology. 1994;21:2286–2291
  18. Smets EM, Garssen B, Bonke B, De Haes JC. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. Journal of Psychosomatic Research. 1995;39:315–325
  19. Haywood KL, Garratt AM, Jordan K, et al. Spinal mobility in ankylosing spondylitis: reliability, validity and responsiveness. Rheumatology (Oxford, England). 2004;43:750–757
  20. Viitanen JV, Heikkila S, Kokko ML, Kautiainen H. Clinical assessment of spinal mobility measurements in ankylosing spondylitis: a compact set for follow-up and trials?. Clinical Rheumatology. 2000;19:131–137
  21. Viitanen JV, Kokko ML, Heikkila S, Kautiainen H. Neck mobility assessment in ankylosing spondylitis: a clinical study of nine measurements including new tape methods for cervical rotation and lateral flexion. British Journal of Rheumatology. 1998;37:377–381
  22. Viitanen JV, Kautiainen H, Suni J, et al. The relative value of spinal and thoracic mobility measurements in ankylosing spondylitis. Scandinavian Journal of Gastroenterology. 1995;24:94–97
  23. Moll JM, Wright V. The pattern of chest and spinal mobility in ankylosing spondylitis. An objective clinical study of 106 patients. Rheumatology and Rehabilitation. 1973;12:115–134
  24. Macrae IF, Wright V. Measurement of back movement. Annals of the Rheumatic Diseases. 1969;28:584–589
  25. Macrae IF, Wright V. Measurement of lumbar spine motion in population studies. Annals of the Rheumatic Diseases. 1969;28:329
  26. Jenkinson TR, Mallorie PA, Whitelock HC, et al. Defining spinal mobility in ankylosing spondylitis (AS). The bath AS metrology index. The Journal of Rheumatology. 1994;21:1694–1698
  27. Heuft-Dorenbosch L, Vosse D, Landewe R, et al. Measurement of spinal mobility in ankylosing spondylitis: comparison of occiput-to-wall and tragus-to-wall distance. The Journal of Rheumatology. 2004;31:1779–1784
  28. Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. Controlled Clinical Trials. 1991;12:142S–158S
  29. Pile KD, Laurent MR, Salmond CE, et al. Clinical assessment of ankylosing spondylitis: a study of observer variation in spinal measurements. British Journal of Rheumatology. 1991;30:29–34
  30. Heikkila S, Viitanen JV, Kautiainen H, Kauppi M. Sensitivity to change of mobility tests; effect of short term intensive physiotherapy and exercise on spinal, hip, and shoulder measurements in spondyloarthropathy. The Journal of Rheumatology. 2000;27:1251–1256
  31. Rahali-Khachlouf H, Poiraudeau S, Fermanian J, et al. [Validity and reliability of spinal clinical measures in ankylosing spondylitis]. Annales de Readaptation et de Medecine Physique. 2001;44:205–212
  32. Kennedy LG, Jenkinson TR, Mallorie PA, et al. Ankylosing spondylitis: the correlation between a new metrology score and radiology. British Journal of Rheumatology. 1995;34:767–770
  33. Wanders A, Landewé R, Dougados M, et al. Association between radiographic damage of the spine and spinal mobility for individual patients with ankylosing spondylitis: can assessment of spinal mobility be a proxy for radiographic evaluation?. Annals of the Rheumatic Diseases. 2005;64:988–994
  34. Jauregui E, Conner-Spady B, Russell AS, Maksymowych WP. Clinimetric evaluation of the bath ankylosing spondylitis metrology index in a controlled trial of pamidronate therapy. The Journal of Rheumatology. 2004;31:2422–2428
  35. Balint PV, Kane D, Wilson H, et al. Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy. Annals of the Rheumatic Diseases. 2002;61:905–910
  36. Mander M, Simpson JM, McLellan A, et al. Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis. Annals of the Rheumatic Diseases. 1987;46:197–202
  37. van der Heijde D, Dijkmans B, Geusens P, et al. Efficacy and safety of infliximab in patients with ankylosing spondylitis. Results of a randomized controlled trial (ASSERT). Arthritis and Rheumatism. 2005;52:582–591
  38. Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A, et al. Assessment of enthesitis in ankylosing spondylitis. Annals of the Rheumatic Diseases. 2003;62:127–132
  39. Braun J, Brandt J, Listing J, et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet. 2002;359:1187–1193
  40. Jones SD, Steiner A, Garrett SL, Calin A. The bath ankylosing spondylitis patient global score (BAS-G). British Journal of Rheumatology. 1996;35:66–71
  41. Pavy S, Brophy S, Calin A. Establishment of the minimum clinically important difference for the bath ankylosing spondylitis indices: a prospective study. The Journal of Rheumatology. 2005;32:80–85
  42. Calin A, Nakache JP, Gueguen A, et al. Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument?. Rheumatology (Oxford, England). 1999;38:878–882
  43. Haywood KL, Garratt AM, Dawes PT. Patient-assessed health in ankylosing spondylitis: a structured review. Rheumatology (Oxford, England). 2005;44:577–586
  44. Cohen JD, Cunin P, Farrenq V, et al. Estimation of the bath ankylosing spondylitis disease activity index cutoff for perceived symptom relief in patients with spondyloarthropathies. The Journal of Rheumatology. 2006;33:79–81
  45. Heuft-Dorenbosch L, van Tubergen A, Spoorenberg A, et al. The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the bath ankylosing spondylitis disease activity index. Arthritis and Rheumatism. 2004;51:154–159
  46. Spoorenberg A, van der Heijde D, de Klerk E, et al. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. The Journal of Rheumatology. 1999;26:980–984
  47. Ruof J, Stucki G. Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review. The Journal of Rheumatology. 1999;26:966–970
  48. Braun J, van der Heijde D, Dougados M, et al. Staging of patients with ankylosing spondylitis: a preliminary proposal. Annals of the Rheumatic Diseases. 2002;61:iii9–iii23
  49. Creemers MCW, Franssen MJAM, van't Hof MA, et al. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Annals of the Rheumatic Diseases. 2005;64:127–129
  50. Wanders AJ, Landewe RB, Spoorenberg A, et al. What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the outcome measures in rheumatology clinical trials filter. Arthritis and Rheumatism. 2004;50:2622–2632
  51. van der Heijde D, Landewé R, the ASAS Working Group . Selection of a method for scoring radiographs for ankylosing spondylitis clinical trials, by the assessment in ankylosing spondylitis working group and OMERACT. The Journal of Rheumatology. 2005;32:2048–2049
  52. Braun J, Bollow M, Sieper J. Radiologic diagnosis and pathology of the spondyloarthropathies. Rheumatic Diseases Clinics of North America. 1998;24:697–735
  53. Braun J, Bollow M, Eggens U, et al. Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients. Arthritis and Rheumatism. 1994;37:1039–1045
  54. Braun J, Golder W, Bollow M, et al. Imaging and scoring in ankylosing spondylitis. Clinical and Experimental Rheumatology. 2002;20:S178–S184
  55. Baraliakos X, Davis J, Tsuji W, Braun J. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept. Arthritis and Rheumatism. 2005;52:1216–1223
  56. Braun J, Baraliakos X, Golder W, et al. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system. Arthritis and Rheumatism. 2003;48:1126–1136
  57. World Health Organisation. International Classification of Functioning, Disability and Health. Geneva: WHO; 2001;
  58. Dagfinrud H, Kjeken I, Mowinckel P, et al. Impact of functional impairment in ankylosing spondylitis: impairment, activity limitation, and participation restrictions. The Journal of Rheumatology. 2005;32:516–523
  59. Sigl T, Cieza A, van der Heijde D, Stucki G. ICF-based comparison of disease-specific instruments measuring physical functional ability for ankylosing spondylitis. Annals of the Rheumatic Diseases. 2005;64:1576–1581
  60. van Echteld I, Cieza A, Boonen A, et al. Identification of the most common problems in patients with ankylosing spondylitis using the international classification of functioning, disability and health. The Journal of Rheumatology. 2006;in press
  61. Cieza A, Geyh S, Chatterji S, et al. ICF linking rules: an update based on lessons learned. Journal of Rehabilitation Medicine. 2005;37:212–218
  62. Cieza A, Brockow T, Ewert T, et al. Linking health-status measurements to the international classification of functioning, disability and health. Journal of Rehabilitation Medicine. 2002;34:205–210
  63. Calin A, Garrett S, Whitelock H, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the bath ankylosing spondylitis functional index. The Journal of Rheumatology. 1994;21:2281–2285
  64. Dougados M, Gueguen A, Nakache JP, et al. Evaluation of a functional index for patients with ankylosing spondylitis. The Journal of Rheumatology. 1990;17:1254–1255
  65. Daltroy LH, Larson MG, Roberts NW, Liang MH. A modification of the health assessment questionnaire for the spondyloarthropathies. The Journal of Rheumatology. 1990;17:946–950
  66. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis and Rheumatism. 1980;23:137–145
  67. Spoorenberg A, van der Heijde D, de Klerk E, et al. A comparative study of the usefulness of the bath ankylosing spondylitis functional index and the dougados functional index in the assessment of ankylosing spondylitis. The Journal of Rheumatology. 1999;26:961–965
  68. Ruof J, Sangha O, Stucki G. Comparative responsiveness of 3 functional indices in ankylosing spondylitis. The Journal of Rheumatology. 1999;26:1959–1963
  69. Ruof J, Stucki G. Comparison of the dougados functional index and the bath ankylosing spondylitis functional index. A literature review. The Journal of Rheumatology. 1999;26:955–960
  70. Doward LC, Spoorenberg A, Cook SA, et al. Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Annals of the Rheumatic Diseases. 2003;62:20–26
  71. Helliwell PS, Marzo-Ortega H, Tennant A. Comparison of a disease-specific and a generic instrument for measuring health-related quality of life in ankylosing spondylitis. Arthritis and Rheumatism. 2002;46:3098
  72. Tan AL, Marzo-Ortega H, O'Connor P, et al. Efficacy of anakinra in active ankylosing spondylitis: a clinical and magnetic resonance imaging study. Annals of the Rheumatic Diseases. 2004;63:1041–1045
  73. van Tubergen A, Landewe R, van der Heijde D, et al. Combined spa-exercise therapy is effective in patients with ankylosing spondylitis: a randomized controlled trial. Arthritis and Rheumatism. 2001;45:430–438
  74. Haywood KL, Garratt M, Jordan K, et al. Disease-specific, patient-assessed measures of health outcome in ankylosing spondylitis: reliability, validity and responsiveness. Rheumatology (Oxford, England). 2002;41:1295–1302
  75. Haywood KL, Garratt AM, Dziedzic K, Dawes PT. Generic measures of health-related quality of life in ankylosing spondylitis: reliability, validity and responsiveness. Rheumatology (Oxford, England). 2002;41:1380–1387
  76. Cieza A, Stucki G. Content comparison of health-related quality of life (HRQOL) instruments based on the international classification of functioning, disability and health (ICF). Quality of Life Research. 2005;14:1225–1237
  77. Anderson JJ, Baron G, van der Heijde D, et al. Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis and Rheumatism. 2001;44:1876–1886
  78. Dougados M, Behier JM, Jolchine I, et al. Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug. Arthritis and Rheumatism. 2001;44:180–185
  79. Dougados M, Nguyen M, Caporal R, et al. Ximoprofen in ankylosing spondylitis. A double blind placebo controlled dose ranging study. Scandinavian Journal of Gastroenterology. 1994;23:243–248
  80. Dougados M, Gueguen A, Nakache JP, et al. Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial. Rheumatology. 1999;38:235–244
  81. Dougados M, Caporal R, Doury P, et al. A double blind crossover placebo controlled trial of ximoprofen in ankylosing spondylitis. The Journal of Rheumatology. 1989;16:1167–1169
  82. Dougados M, Gueguen A, Nakache JP, et al. Evaluation of a functional index and an articular index in ankylosing spondylitis. The Journal of Rheumatology. 1988;15:302–307
  83. van Tubergen A, van der Heijde D, Anderson J, et al. Comparison of statistically derived ASAS improvement criteria for ankylosing spondylitis with clinically relevant improvement according to an expert panel. Annals of the Rheumatic Diseases. 2003;62:215–221
  84. Stone MA, Inman RD, Wright JG, Maetzel A. Validation exercise of the ankylosing spondylitis assessment study (ASAS) group response criteria in ankylosing spondylitis patients treated with biologics. Arthritis and Rheumatism. 2004;51:316–320
  85. Brandt J, Listing J, Sieper J, et al. Development and preselection of criteria for short term improvement after anti-TNF alpha treatment in ankylosing spondylitis. Annals of the Rheumatic Diseases. 2004;63:1438–1444
  86. Braun J, Pham T, Sieper J, et al. International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Annals of the Rheumatic Diseases. 2003;62:817–824
  87. Braun J, Davis J, Dougados M, et al. First update of the International ASAS Consensus Statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Annals of the Rheumatic Diseases. 2006;65:316–320

PII: S1521-6942(06)00041-6

doi: 10.1016/j.berh.2006.03.011

Best Practice & Research Clinical Rheumatology
Volume 20, Issue 3 , Pages 521-537 , June 2006

Article Tools

* Image Usage & Resolution